Research highlights the benefits of a comprehensive strategy, involving nutritional optimization, psychological assessment, and addressing septic complications before surgery. Despite many CD patients being on immune-suppressing medications, studies indicate that most of these medications are safe to use and should not delay surgery. However, a personalized approach for each case is needed. This review underscores the importance of multi-disciplinary team led peri-operative management of CD patients. We suggest that this can be done at a dedicated perioperative clinic for prehabilitation, with the potential to enhance outcomes for CD patients undergoing surgery.
Keyphrases
- minimally invasive
- patients undergoing
- end stage renal disease
- ejection fraction
- newly diagnosed
- coronary artery bypass
- peritoneal dialysis
- signaling pathway
- type diabetes
- primary care
- patient reported outcomes
- adipose tissue
- cardiac surgery
- insulin resistance
- physical activity
- depressive symptoms
- risk assessment
- acute coronary syndrome
- nk cells
- risk factors
- human health
- clinical evaluation